Showing results (1131-1140 of 1,163) with videos related to

Sort By:
Pageof 117
Blood Neoplasia|July 25, 2026
Hypomethylating agents-venetoclax as salvage therapy for relapse of AML and MDS after allogeneic HCTDiana T Samuels, Brian J Ball, Ni-Chun Tsai, et al.
Genome Research|July 7, 2005
Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general populationKhalid K Alharbi, Mohammed A Aldahmesh, Emmanuel Spanakis, et al.
Bone Marrow Transplantation|February 27, 2025
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effectPaul B Koller, Tamer Othman, Dongyun Yang, et al.
Nature|September 21, 2022
Aerial additive manufacturing with multiple autonomous robotsKetao Zhang, Pisak Chermprayong, Feng Xiao, et al.
International Journal of Molecular Sciences|October 27, 2022
Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination RegimesAlexandru Odainic, Jasper Spitzer, Jennifer Barbara Szlapa, et al.
British Journal of Cancer|February 21, 2024
CAnceR IN PreGnancy (CARING) - a retrospective study of cancer diagnosed during pregnancy in the United KingdomM A Baxter, M Denholm, S J Kingdon, et al.
Nature|December 2, 2005
A soft solid surface on Titan as revealed by the Huygens Surface Science PackageJohn C Zarnecki, Mark R Leese, Brijen Hathi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 30, 2020
Developments in the Histopathological Classification of ANCA-Associated GlomerulonephritisEmma E van Daalen, Maria A C Wester Trejo, Arda Göçeroğlu, et al.
Blood Advances|May 4, 2023
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemiaJoseph G W McCarter, David Nemirovsky, Christopher A Famulare, et al.
Journal of Medicinal Chemistry|September 25, 2025
Discovery of Potent and Selective Reversible Ubiquitin-Like Modifier Activating Enzyme 5 Inhibitors Targeting the UFMylation PathwayJames J Mignone, Elizabeth A Jurica, Deepa Rajasekaran, et al.
Pageof 117